Overweight and obesity represent major public health challenges worldwide. Obesity is recognized by the World Health Organization (WHO) as a chronic, relapsing disease, and current projections suggest that more than half of the global adult population will be living with overweight or obesity by 2030.The emergence of drugs based on glucagon-like peptide-1 (GLP-1) receptor agonism […]
